A. Gokyer Et Al. , "Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib," CLINICAL & TRANSLATIONAL ONCOLOGY , vol.21, no.11, pp.1518-1523, 2019
Gokyer, A. Et Al. 2019. Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib. CLINICAL & TRANSLATIONAL ONCOLOGY , vol.21, no.11 , 1518-1523.
Gokyer, A., Kucukarda, A., Kostek, O., Hacioglu, M. B., Sunal, B. S., Demircan, N. C., ... UZUNOĞLU, S.(2019). Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib. CLINICAL & TRANSLATIONAL ONCOLOGY , vol.21, no.11, 1518-1523.
Gokyer, A. Et Al. "Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib," CLINICAL & TRANSLATIONAL ONCOLOGY , vol.21, no.11, 1518-1523, 2019
Gokyer, A. Et Al. "Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib." CLINICAL & TRANSLATIONAL ONCOLOGY , vol.21, no.11, pp.1518-1523, 2019
Gokyer, A. Et Al. (2019) . "Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib." CLINICAL & TRANSLATIONAL ONCOLOGY , vol.21, no.11, pp.1518-1523.
@article{article, author={A. Gokyer Et Al. }, title={Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib}, journal={CLINICAL & TRANSLATIONAL ONCOLOGY}, year=2019, pages={1518-1523} }